Cancer Treatment Reviews is an Elsevier review journal, published six times a year since 1974, that gives oncologists overviews of drugs, combinations and treatment strategies across systemic therapy, radiotherapy, surgery and supportive care. It is read by clinicians rather than laboratory scientists.
Cancer Treatment Reviews is a review journal published by Elsevier six times a year and registered with Crossref under that publisher. NLM records that it began in 1974 with Academic Press in London and New York, with K. Hellmann and S. K. Carter as founding editors, and that it is currently indexed for MEDLINE. It publishes reviews on the treatment of cancer, spanning systemic therapy, radiotherapy, surgery and supportive care.
Medical oncologist who leads cancer services at Cork University Hospital as Clinical Director, with a focus on gynaecological and thoracic cancers and early-phase trials.
Marseille neuro-oncologist who was lead author of AVAglio, the trial that showed adding bevacizumab to standard glioblastoma treatment delays progression but does not lengthen life.
Academician of the Chinese Academy of Engineering who is President of Shandong Cancer Hospital and Institute, the provincial cancer hospital in Jinan.
Shares Palliative, PubMed & Europe PMC.
Shares Palliative, PubMed & Europe PMC.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Palliative, Radiotherapy.
Shares Palliative, PubMed & Europe PMC.
Shares Palliative, PubMed & Europe PMC.